MedTrace Logo

Global Lomitapide Pregnancy Exposure Registry

NCT02399839 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2022-12-16

No results posted yet for this study

Summary

To evaluate the outcomes of pregnancy in women treated with lomitapide.

Conditions

  • Pregnancy

Interventions

DRUG

lomitapide

As prescribed by Physician.

Sponsors & Collaborators

  • Amryt Pharma

    lead INDUSTRY

Principal Investigators

  • Sallyann O'Brien · Amryt Pharmaceuticals

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02399839 on ClinicalTrials.gov